Trial Profile
A Multicenter, Randomized, Double-Blind, Dose-Ranging, Phase II Study to Assess the Efficacy and Safety of the 100, 150 and 200 Mcg Misoprostol Vaginal Insert for Women Requiring Cervical Ripening and Induction of Labor.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Misoprostol (Primary)
- Indications Labour disorders
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 16 Jun 2010 Results released in a Cytokine PharmaSciences media release.
- 14 Nov 2009 Actual patient number (370) added as reported by ClinicalTrials.gov.
- 14 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.